| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.81B | 101.91B | 94.04B | 101.67B | 104.72B | 83.54B |
| Gross Profit | 10.38B | 10.43B | 10.85B | 10.96B | 9.87B | 7.73B |
| EBITDA | 3.91B | 3.23B | 1.80B | 3.04B | 3.51B | 3.29B |
| Net Income | 1.94B | 1.36B | -319.00M | 1.06B | 1.58B | 1.52B |
Balance Sheet | ||||||
| Total Assets | 53.40B | 53.16B | 51.61B | 50.88B | 52.51B | 43.19B |
| Cash, Cash Equivalents and Short-Term Investments | 13.43B | 13.59B | 11.00B | 10.13B | 11.40B | 12.70B |
| Total Debt | 3.35B | 3.90B | 5.38B | 6.62B | 5.57B | 6.65B |
| Total Liabilities | 35.47B | 35.45B | 35.40B | 34.10B | 35.59B | 31.02B |
| Stockholders Equity | 17.79B | 17.60B | 16.18B | 16.70B | 16.82B | 12.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.85B | 2.37B | 564.00M | 3.79B | 2.09B |
| Operating Cash Flow | 0.00 | 3.93B | 3.17B | 1.92B | 4.63B | 2.54B |
| Investing Cash Flow | 0.00 | 137.00M | -688.00M | -3.07B | -7.83B | -1.27B |
| Financing Cash Flow | 0.00 | -1.53B | -1.65B | -276.00M | 2.09B | 3.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥3.76B | 10.37 | ― | 2.95% | 1.41% | -6.45% | |
74 Outperform | ¥15.09B | 10.61 | ― | 3.16% | -7.41% | -17.57% | |
72 Outperform | ¥24.87B | 22.08 | ― | 2.01% | 6.10% | ― | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | ¥10.58B | 14.53 | ― | 1.06% | 0.02% | -88.78% | |
55 Neutral | ¥486.38B | 162.08 | ― | 0.98% | 1.96% | -45.28% | |
48 Neutral | ¥9.47B | 35.35 | ― | 1.02% | -8.03% | ― |